Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xingnao Dripping Pills for Vascular Dementia (Phase III)
CTR20132595Phase 3Active
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Xingnao Dripping Pills in vascular dementia, sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jan 2014; status: active.
02
Drugs
Xingnao Dripping Pills
03
Conditions
vascular dementia
Beyond the preview
Go deeper on CTR20132595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132595.